September 05, 2024

Youth E-Cigarette Use Plummeted in 2024

Youth e-cigarette use plummeted by 23.4% in 2024, with 500,000 fewer users compared to 2023, marking the lowest level in a decade and potentially signaling a shift in adolescent respiratory health trends.

Conexiant

August 29, 2024

Under 30? ID Now Required for Cigarettes, Vapes

The FDA raises the minimum age for purchasing tobacco products, now requiring identification verification for individuals under 30 and prohibiting vending machine sales in the presence of individuals under 21.

Reuters

August 29, 2024

CDC Releases 2024-2025 Flu Vaccine Guidance

The CDC's ACIP recommended annual trivalent flu vaccines for 2024-25, with specific guidance for older adults, immunosuppressed patients, and pregnant individuals, based on data showing substantial reductions in influenza-related illnesses, medical visits, hospitalizations and deaths.

Conexiant

August 28, 2024

FDA Approves Cancer Biomarker Test, Companion Diagnostic Indications

The FDA has approved the in vitro diagnostic TruSight Oncology Comprehensive test and its first two companion diagnostic indications. This targeted sequencing panel interrogates over 500 genes to prof...

The ASCO Post

August 23, 2024

Free COVID Tests Available for Fall Campaign

The U.S. government is launching a fall campaign to provide free COVID-19 tests by mail and encourage vaccinations against COVID, flu, and RSV.

Reuters

August 20, 2024

FDA Approves Non-Chemo Lung Cancer Treatment

FDA Approves Johnson & Johnson's Innovative Chemotherapy-Free Treatment for Lung Cancer, Offering New Hope for Patients with EGFR Mutation.

Conexiant

August 19, 2024

Treprostinil Approval Stalled by FDA

Liquidia’s treprostinil inhaler received tentative approval but faced exclusivity hurdles.

Reuters

August 16, 2024

FDA Approves Durvalumab for Resectable NSCLC

Findings from the AEGEAN trial backed the FDA's approval of the immunotherapy.

Conexiant

August 16, 2024

Two Docs Charged in Matthew Perry's Death

The indictment details how Dr. Plasencia, upon learning of Perry's interest in ketamine, conspired with Dr. Chavez to obtain and sell the drug to the actor.

Conexiant